| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplastic Stem Cells | 7 | 2025 | 330 | 1.530 |
Why?
|
| Glioblastoma | 5 | 2023 | 372 | 1.310 |
Why?
|
| Neoplasms | 7 | 2023 | 2973 | 0.960 |
Why?
|
| Pyrans | 2 | 2021 | 6 | 0.770 |
Why?
|
| Phosphoproteins | 3 | 2025 | 450 | 0.720 |
Why?
|
| Antineoplastic Agents | 3 | 2021 | 1800 | 0.690 |
Why?
|
| Pancreatic Neoplasms | 7 | 2020 | 736 | 0.630 |
Why?
|
| RNA-Binding Proteins | 2 | 2025 | 538 | 0.610 |
Why?
|
| Endothelial Cells | 1 | 2023 | 520 | 0.610 |
Why?
|
| Tumor Microenvironment | 3 | 2025 | 707 | 0.580 |
Why?
|
| Molecular Targeted Therapy | 2 | 2021 | 384 | 0.570 |
Why?
|
| Genes, Neoplasm | 1 | 2018 | 80 | 0.550 |
Why?
|
| Cell Line, Tumor | 17 | 2025 | 3715 | 0.540 |
Why?
|
| Antineoplastic Agents, Phytogenic | 4 | 2018 | 100 | 0.460 |
Why?
|
| Brain Neoplasms | 3 | 2020 | 1306 | 0.440 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2025 | 2008 | 0.430 |
Why?
|
| Neoplastic Cells, Circulating | 2 | 2025 | 75 | 0.420 |
Why?
|
| Neoplasm Proteins | 1 | 2018 | 679 | 0.420 |
Why?
|
| Aptamers, Nucleotide | 2 | 2025 | 37 | 0.420 |
Why?
|
| Cell Proliferation | 10 | 2025 | 2461 | 0.410 |
Why?
|
| Neuroblastoma | 1 | 2019 | 543 | 0.400 |
Why?
|
| Biomarkers | 1 | 2023 | 3385 | 0.400 |
Why?
|
| Hedgehog Proteins | 3 | 2020 | 198 | 0.390 |
Why?
|
| Triterpenes | 2 | 2018 | 22 | 0.390 |
Why?
|
| Lung Neoplasms | 4 | 2025 | 1547 | 0.370 |
Why?
|
| Signal Transduction | 9 | 2025 | 4669 | 0.290 |
Why?
|
| Pancreatic Stellate Cells | 2 | 2020 | 7 | 0.280 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 2599 | 0.280 |
Why?
|
| Cancer Pain | 2 | 2019 | 25 | 0.270 |
Why?
|
| Calcitonin Gene-Related Peptide | 2 | 2019 | 86 | 0.260 |
Why?
|
| G-Quadruplexes | 2 | 2025 | 11 | 0.260 |
Why?
|
| Nigella | 1 | 2006 | 1 | 0.250 |
Why?
|
| Stilbenes | 2 | 2017 | 35 | 0.250 |
Why?
|
| Stress, Psychological | 3 | 2022 | 539 | 0.240 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2021 | 174 | 0.240 |
Why?
|
| Humans | 33 | 2025 | 130432 | 0.240 |
Why?
|
| src-Family Kinases | 1 | 2025 | 93 | 0.220 |
Why?
|
| Receptors, CXCR4 | 1 | 2025 | 69 | 0.220 |
Why?
|
| alpha-Synuclein | 1 | 2026 | 141 | 0.210 |
Why?
|
| Cadherins | 1 | 2025 | 184 | 0.200 |
Why?
|
| Mice, Nude | 6 | 2025 | 698 | 0.200 |
Why?
|
| DNA Modification Methylases | 1 | 2023 | 44 | 0.190 |
Why?
|
| Peptides | 1 | 2026 | 705 | 0.190 |
Why?
|
| Methyltransferases | 1 | 2023 | 78 | 0.190 |
Why?
|
| Nerve Growth Factor | 2 | 2019 | 19 | 0.180 |
Why?
|
| Depression | 3 | 2022 | 1312 | 0.180 |
Why?
|
| Wakefulness | 1 | 2023 | 103 | 0.180 |
Why?
|
| Animals | 19 | 2026 | 33844 | 0.180 |
Why?
|
| Parkinson Disease | 2 | 2026 | 722 | 0.170 |
Why?
|
| Brain | 2 | 2026 | 3170 | 0.170 |
Why?
|
| Autophagy-Related Protein 5 | 1 | 2021 | 13 | 0.170 |
Why?
|
| Binding Sites | 2 | 2025 | 1136 | 0.170 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2025 | 616 | 0.170 |
Why?
|
| Disease Progression | 3 | 2023 | 2191 | 0.160 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2019 | 254 | 0.160 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2026 | 1107 | 0.160 |
Why?
|
| Medicare | 1 | 2024 | 442 | 0.160 |
Why?
|
| Enzyme Inhibitors | 1 | 2023 | 559 | 0.160 |
Why?
|
| Astrocytes | 1 | 2023 | 268 | 0.160 |
Why?
|
| DNA-Binding Proteins | 2 | 2021 | 1946 | 0.160 |
Why?
|
| Substance P | 2 | 2019 | 31 | 0.160 |
Why?
|
| Caveolin 1 | 1 | 2020 | 51 | 0.160 |
Why?
|
| Survival Rate | 3 | 2024 | 2112 | 0.160 |
Why?
|
| SMARCB1 Protein | 1 | 2020 | 41 | 0.160 |
Why?
|
| Mice | 12 | 2025 | 18210 | 0.150 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2025 | 817 | 0.150 |
Why?
|
| Glutamic Acid | 1 | 2020 | 192 | 0.150 |
Why?
|
| Spinal Cord | 1 | 2021 | 256 | 0.150 |
Why?
|
| Machine Learning | 1 | 2023 | 379 | 0.150 |
Why?
|
| Colorectal Neoplasms | 1 | 2025 | 620 | 0.150 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2020 | 137 | 0.140 |
Why?
|
| Antigens, CD34 | 1 | 2019 | 97 | 0.140 |
Why?
|
| Ischemic Postconditioning | 1 | 2018 | 4 | 0.140 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2019 | 112 | 0.140 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2018 | 31 | 0.140 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2023 | 481 | 0.140 |
Why?
|
| ErbB Receptors | 2 | 2023 | 289 | 0.140 |
Why?
|
| Deoxycytidine | 1 | 2018 | 81 | 0.140 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2018 | 20 | 0.140 |
Why?
|
| Cognitive Dysfunction | 1 | 2023 | 337 | 0.140 |
Why?
|
| Glypicans | 1 | 2018 | 36 | 0.140 |
Why?
|
| Fluorouracil | 1 | 2018 | 132 | 0.140 |
Why?
|
| Neoplasm Metastasis | 3 | 2025 | 713 | 0.130 |
Why?
|
| Extracellular Matrix | 1 | 2019 | 232 | 0.130 |
Why?
|
| DNA | 1 | 2023 | 1399 | 0.130 |
Why?
|
| Menopause | 1 | 2018 | 86 | 0.130 |
Why?
|
| Axons | 1 | 2021 | 389 | 0.130 |
Why?
|
| Cerebral Cortex | 1 | 2021 | 448 | 0.130 |
Why?
|
| Tumor Cells, Cultured | 1 | 2019 | 975 | 0.130 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2018 | 186 | 0.130 |
Why?
|
| beta Catenin | 1 | 2018 | 198 | 0.130 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2026 | 3752 | 0.130 |
Why?
|
| Ornithine | 1 | 2016 | 31 | 0.120 |
Why?
|
| Vitis | 1 | 2016 | 13 | 0.120 |
Why?
|
| DNA Methylation | 1 | 2023 | 1080 | 0.120 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 899 | 0.120 |
Why?
|
| Nitrosamines | 1 | 2016 | 15 | 0.120 |
Why?
|
| Securin | 1 | 2015 | 4 | 0.120 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2016 | 57 | 0.120 |
Why?
|
| Nerve Growth Factors | 1 | 2016 | 67 | 0.120 |
Why?
|
| Rats | 4 | 2026 | 3379 | 0.120 |
Why?
|
| MicroRNAs | 1 | 2023 | 888 | 0.120 |
Why?
|
| Apoptosis | 5 | 2018 | 1829 | 0.120 |
Why?
|
| TRPV Cation Channels | 1 | 2016 | 46 | 0.120 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2025 | 613 | 0.120 |
Why?
|
| Carcinogens | 1 | 2016 | 128 | 0.120 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2016 | 93 | 0.110 |
Why?
|
| Saponins | 2 | 2023 | 20 | 0.110 |
Why?
|
| Antidepressive Agents | 1 | 2018 | 318 | 0.110 |
Why?
|
| Transcription Factors | 1 | 2025 | 2420 | 0.110 |
Why?
|
| Shock, Septic | 1 | 2016 | 149 | 0.110 |
Why?
|
| Ischemia | 1 | 2018 | 362 | 0.110 |
Why?
|
| Alzheimer Disease | 1 | 2023 | 878 | 0.110 |
Why?
|
| Molecular Docking Simulation | 2 | 2026 | 150 | 0.110 |
Why?
|
| Exosomes | 1 | 2015 | 61 | 0.110 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2014 | 7 | 0.110 |
Why?
|
| Blotting, Western | 4 | 2018 | 1016 | 0.110 |
Why?
|
| Frontotemporal Dementia | 1 | 2015 | 65 | 0.110 |
Why?
|
| Glutamates | 1 | 2014 | 51 | 0.110 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2014 | 56 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2015 | 186 | 0.110 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2014 | 25 | 0.100 |
Why?
|
| Sp1 Transcription Factor | 1 | 2014 | 38 | 0.100 |
Why?
|
| Mice, Inbred BALB C | 3 | 2025 | 977 | 0.100 |
Why?
|
| Sumoylation | 1 | 2014 | 47 | 0.100 |
Why?
|
| Algorithms | 1 | 2020 | 1662 | 0.100 |
Why?
|
| Transcriptome | 1 | 2020 | 1111 | 0.100 |
Why?
|
| Lens, Crystalline | 1 | 2014 | 104 | 0.100 |
Why?
|
| Behavior, Animal | 3 | 2022 | 490 | 0.100 |
Why?
|
| Female | 11 | 2024 | 70362 | 0.090 |
Why?
|
| Prognosis | 2 | 2019 | 4861 | 0.090 |
Why?
|
| NF-kappa B | 1 | 2014 | 440 | 0.090 |
Why?
|
| Cell Movement | 3 | 2025 | 873 | 0.090 |
Why?
|
| Genomics | 1 | 2020 | 1616 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 479 | 0.090 |
Why?
|
| Ovarian Neoplasms | 1 | 2015 | 422 | 0.090 |
Why?
|
| Disease Models, Animal | 4 | 2026 | 4669 | 0.090 |
Why?
|
| Biomarkers, Tumor | 1 | 2019 | 1582 | 0.080 |
Why?
|
| Epithelial Cells | 1 | 2014 | 907 | 0.080 |
Why?
|
| Male | 9 | 2026 | 64470 | 0.080 |
Why?
|
| Gene Regulatory Networks | 2 | 2023 | 376 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 1362 | 0.070 |
Why?
|
| Mutation | 4 | 2023 | 6092 | 0.070 |
Why?
|
| Oleanolic Acid | 1 | 2006 | 7 | 0.060 |
Why?
|
| Growth Inhibitors | 1 | 2006 | 35 | 0.060 |
Why?
|
| Cell Differentiation | 1 | 2014 | 1919 | 0.060 |
Why?
|
| Cells, Cultured | 2 | 2015 | 2896 | 0.060 |
Why?
|
| RNA, Small Interfering | 2 | 2018 | 665 | 0.060 |
Why?
|
| Pancreas | 2 | 2018 | 219 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 2333 | 0.060 |
Why?
|
| SELEX Aptamer Technique | 1 | 2025 | 5 | 0.060 |
Why?
|
| Aged | 6 | 2024 | 20882 | 0.060 |
Why?
|
| RNA Interference | 2 | 2018 | 493 | 0.060 |
Why?
|
| Blood-Brain Barrier | 1 | 2026 | 154 | 0.060 |
Why?
|
| Autophagy | 2 | 2021 | 422 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2021 | 2332 | 0.050 |
Why?
|
| Anoikis | 1 | 2023 | 8 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 3 | 2021 | 4711 | 0.050 |
Why?
|
| Supratentorial Neoplasms | 1 | 2024 | 38 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2018 | 1000 | 0.050 |
Why?
|
| Cisplatin | 1 | 2025 | 274 | 0.050 |
Why?
|
| Arousal | 1 | 2023 | 75 | 0.050 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2024 | 134 | 0.050 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2024 | 214 | 0.050 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2024 | 216 | 0.050 |
Why?
|
| 3' Untranslated Regions | 1 | 2023 | 155 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 1207 | 0.050 |
Why?
|
| Metformin | 1 | 2024 | 171 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 1596 | 0.040 |
Why?
|
| Protein Binding | 1 | 2025 | 1656 | 0.040 |
Why?
|
| Calcium Signaling | 1 | 2023 | 245 | 0.040 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2022 | 150 | 0.040 |
Why?
|
| Proteomics | 1 | 2025 | 616 | 0.040 |
Why?
|
| Proton Magnetic Resonance Spectroscopy | 1 | 2020 | 24 | 0.040 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2020 | 26 | 0.040 |
Why?
|
| Electromyography | 1 | 2021 | 137 | 0.040 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2019 | 15 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2024 | 6794 | 0.040 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2020 | 95 | 0.040 |
Why?
|
| Sleep | 1 | 2023 | 371 | 0.040 |
Why?
|
| Middle Aged | 5 | 2018 | 28393 | 0.040 |
Why?
|
| Heterografts | 1 | 2020 | 191 | 0.040 |
Why?
|
| Glutamine | 1 | 2020 | 201 | 0.040 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2020 | 175 | 0.040 |
Why?
|
| Neovascularization, Pathologic | 1 | 2020 | 227 | 0.040 |
Why?
|
| Pentacyclic Triterpenes | 1 | 2018 | 8 | 0.040 |
Why?
|
| Adenylate Kinase | 1 | 2018 | 12 | 0.040 |
Why?
|
| Phenotype | 2 | 2021 | 4475 | 0.040 |
Why?
|
| Malondialdehyde | 1 | 2018 | 49 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2018 | 120 | 0.040 |
Why?
|
| Peroxidase | 1 | 2018 | 63 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2022 | 499 | 0.040 |
Why?
|
| Carthamus tinctorius | 1 | 2018 | 1 | 0.040 |
Why?
|
| Salvia miltiorrhiza | 1 | 2018 | 2 | 0.040 |
Why?
|
| Biogenic Monoamines | 1 | 2018 | 4 | 0.040 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2018 | 57 | 0.030 |
Why?
|
| Alanine Transaminase | 1 | 2018 | 154 | 0.030 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2018 | 82 | 0.030 |
Why?
|
| Metabolomics | 1 | 2022 | 501 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 2018 | 176 | 0.030 |
Why?
|
| Reperfusion Injury | 1 | 2018 | 108 | 0.030 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2006 | 971 | 0.030 |
Why?
|
| Abdominal Pain | 1 | 2019 | 315 | 0.030 |
Why?
|
| Adult | 4 | 2020 | 31124 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 302 | 0.030 |
Why?
|
| Wnt Signaling Pathway | 1 | 2018 | 209 | 0.030 |
Why?
|
| Cecum | 1 | 2016 | 26 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2018 | 336 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 785 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 585 | 0.030 |
Why?
|
| Hippocampus | 1 | 2022 | 796 | 0.030 |
Why?
|
| Thymus Gland | 1 | 2016 | 105 | 0.030 |
Why?
|
| Pedigree | 1 | 2020 | 1673 | 0.030 |
Why?
|
| Capsaicin | 1 | 2016 | 19 | 0.030 |
Why?
|
| Cell Survival | 1 | 2018 | 834 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2018 | 525 | 0.030 |
Why?
|
| Ganglia, Spinal | 1 | 2016 | 65 | 0.030 |
Why?
|
| Atrophy | 1 | 2016 | 248 | 0.030 |
Why?
|
| Protein Interaction Maps | 1 | 2016 | 93 | 0.030 |
Why?
|
| Prions | 1 | 2015 | 19 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2016 | 230 | 0.030 |
Why?
|
| Nanotubes | 1 | 2015 | 16 | 0.030 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2016 | 90 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 2016 | 271 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 2015 | 308 | 0.030 |
Why?
|
| Texas | 1 | 2024 | 3644 | 0.030 |
Why?
|
| Immunotherapy | 1 | 2020 | 760 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2015 | 142 | 0.030 |
Why?
|
| Lipids | 1 | 2018 | 559 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2016 | 304 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2018 | 1571 | 0.030 |
Why?
|
| Glycolysis | 1 | 2015 | 174 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 382 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2015 | 296 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2016 | 317 | 0.030 |
Why?
|
| K562 Cells | 1 | 2014 | 97 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2024 | 5035 | 0.030 |
Why?
|
| Young Adult | 2 | 2020 | 9997 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2016 | 418 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 308 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2014 | 52 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2016 | 410 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2014 | 235 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2014 | 159 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2014 | 190 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2014 | 223 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2022 | 1712 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2016 | 826 | 0.020 |
Why?
|
| Drug Design | 1 | 2014 | 162 | 0.020 |
Why?
|
| DNA Primers | 1 | 2014 | 600 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2016 | 1483 | 0.020 |
Why?
|
| Computational Biology | 1 | 2018 | 862 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 526 | 0.020 |
Why?
|
| Fibroblast Growth Factors | 1 | 2014 | 171 | 0.020 |
Why?
|
| Leukemia | 1 | 2014 | 375 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2020 | 2826 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1610 | 0.020 |
Why?
|
| Smoking | 1 | 2016 | 929 | 0.020 |
Why?
|
| Cytokines | 1 | 2016 | 1344 | 0.020 |
Why?
|
| Mitochondria | 1 | 2015 | 776 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2014 | 710 | 0.020 |
Why?
|
| Inflammation | 1 | 2016 | 1484 | 0.020 |
Why?
|
| Liver | 1 | 2016 | 1790 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 3406 | 0.020 |
Why?
|
| United States | 1 | 2024 | 11871 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2024 | 17522 | 0.010 |
Why?
|
| Time Factors | 1 | 2014 | 6204 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2017 | 8530 | 0.010 |
Why?
|
| Infant | 1 | 2017 | 13230 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 12845 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2017 | 14948 | 0.010 |
Why?
|
| Adolescent | 1 | 2017 | 20732 | 0.010 |
Why?
|
| Child | 1 | 2017 | 26105 | 0.010 |
Why?
|